Significance of Immunotyping by CD8 and PD-L1 Immune Checkpoint Inhibitor in Epithelial Ovarian Carcinoma

被引：0
|
作者：
Srinivasan, Radhika [1 ]
Bansal, Akriti [1 ]
Rohilla, Manish [1 ]
Rai, Bhavana [1 ]
Rajwanshi, Arvind [1 ]
Suri, Vanita [1 ]
Saha, Subhas [2 ]
机构：
[1] Postgrad Inst Med Educ & Res, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Obstet & Gynecol, Chandigarh, India
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1191
引用
收藏
页码：1137 / 1139
页数：3
相关论文
共 50 条
  • [31] PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus
    Marchevsky, Alberto M.
    Watts, Ann E.
    HUMAN PATHOLOGY, 2017, 60 : 16 - 23
  • [32] Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer
    Ghiringhelli, Francois
    Bibeau, Frederic
    Greillier, Laurent
    Fumet, Jean-David
    Ilie, Alis
    Monville, Florence
    Lauge, Caroline
    Catteau, Aurelie
    Boquet, Isabelle
    Majdi, Amine
    Morgand, Erwan
    Oulkhouir, Youssef
    Brandone, Nicolas
    Adam, Julien
    Sbarrato, Thomas
    Kassambara, Alboukadel
    Fieschi, Jacques
    Garcia, Stephane
    Lepage, Anne Laure
    Tomasini, Pascale
    Galon, Jerome
    EBIOMEDICINE, 2023, 92
  • [33] Immunotyping in tubo-ovarian high-grade serous carcinoma by PD-L1 and CD8+T-lymphocytes predicts disease-free survival
    Bansal, Akriti
    Srinivasan, Radhika
    Rohilla, Manish
    Rai, Bhavana
    Rajwanshi, Arvind
    Suri, Vanita
    Chandra Saha, Subhas
    APMIS, 2021, 129 (05) : 254 - 264
  • [34] Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study
    Dergham, Ana Paula
    de Paula, Caroline Busatta Vaz
    Nagashima, Seigo
    Olandoski, Marcia
    de Noronha, Lucia
    Sotomaior, Vanessa Santos
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (07):
  • [35] Clinical Value of Expression of PD-L1 and CD8 of 58 Cases with NSCLC
    Wu, H.
    Zhang, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1994 - S1994
  • [36] Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma
    Nowicki, Theodore S.
    Akiyama, Ryan
    Huang, Rong Rong
    Shintaku, I. Peter
    Wang, Xiaoyan
    Tumeh, Paul C.
    Singh, Arun
    Chmielowski, Bartosz
    Denny, Christopher
    Federman, Noah
    Ribas, Antoni
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (02) : 118 - 126
  • [37] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [38] Relationship Between PD-L1, PD-1, CD8 and Clinicopathological Factors in Primary SCCs
    Vasilev, Preslav
    Popovska, Savelina
    Kraevska, Elitsa Petrova
    Karamanliev, Martin
    Dimitrov, Dobromir
    Yordanova, Ivelina
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (03):
  • [39] Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
    Thompson, Elizabeth D.
    Zahurak, Marianna
    Murphy, Adrian
    Cornish, Toby
    Cuka, Nathan
    Abdelfatah, Eihab
    Yang, Stephen
    Duncan, Mark
    Ahuja, Nita
    Taube, Janis M.
    Anders, Robert A.
    Kelly, Ronan J.
    GUT, 2017, 66 (05) : 794 - 801
  • [40] The Association between SOX2 and PD-L1/CD8 Expression and Their Prognostic Significance in Patients with Resected Lung Squamous Cell Carcinoma
    Xi, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2375 - S2375
12345